During FDA panel discussions at the conclusion of recent ISPE Aseptic Conferences, FDA representatives have repeatedly indicated that they expect facilities equipped with a minimum of RABS to receive less scrutiny than facilities with traditional aseptic processing setups. They said that facilities ...